A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
收藏DataCite Commons2025-12-23 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012460/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is being carried out to see if a new drug called ticagrelor given twice daily in addition to the ASA therapy decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack, or stroke).
提供机构：
Vivli
创建时间：
2025-12-23
